Atlas Trials

Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects

Clinical trial NCT04322227 · TERMINATED

Trial details

NCT number
NCT04322227
Sponsor
H. Lundbeck A/S
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson DiseaseHealthy
Start date
2020-01-23
Primary completion
2020-05-30
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.